Page last updated: 2024-09-04

sk&f 83959 and Dyskinesia Syndromes

sk&f 83959 has been researched along with Dyskinesia Syndromes in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Croke, DT; Harvey, RP; Kinsella, A; Koshikawa, N; Lai, D; O'Sullivan, GJ; O'Tuathaigh, CM; Tighe, O; Tomiyama, K; Waddington, JL	1
Drago, J; Ehrlich, ME; Kim, HA; Kinsella, A; Koshikawa, N; Lawrence, AJ; Schütz, G; Tomiyama, K; Waddington, JL	1

Other Studies

2 other study(ies) available for sk&f 83959 and Dyskinesia Syndromes

Article	Year
Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' mice. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Mar-17, Volume: 33, Issue:2 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Dopamine Agonists; Jaw; Mice; Mice, Inbred C57BL; Mice, Knockout; Movement; Movement Disorders; Neuregulin-1; Phenotype; Receptors, Dopamine D1; Tongue	2009
Phenotypic disruption to orofacial movement topography in conditional mutants with generalized CamKIIa/Cre D1Tox versus striatal-specific DARPP-32/Cre D1Tox ablation of D1 dopamine receptor-expressing cells. Synapse (New York, N.Y.), 2011, Volume: 65, Issue:9 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Corpus Striatum; Diphtheria Toxin; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Dose-Response Relationship, Drug; Face; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Movement; Movement Disorders; Mutation; Neurons; Peptide Fragments; Phenotype; Receptors, Dopamine D1; Time Factors	2011

Article

Year

Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' mice.

Progress in neuro-psychopharmacology & biological psychiatry, 2009, Mar-17, Volume: 33, Issue:2

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Dopamine Agonists; Jaw; Mice; Mice, Inbred C57BL; Mice, Knockout; Movement; Movement Disorders; Neuregulin-1; Phenotype; Receptors, Dopamine D1; Tongue

2009

Phenotypic disruption to orofacial movement topography in conditional mutants with generalized CamKIIa/Cre D1Tox versus striatal-specific DARPP-32/Cre D1Tox ablation of D1 dopamine receptor-expressing cells.

Synapse (New York, N.Y.), 2011, Volume: 65, Issue:9

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Corpus Striatum; Diphtheria Toxin; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Dose-Response Relationship, Drug; Face; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Movement; Movement Disorders; Mutation; Neurons; Peptide Fragments; Phenotype; Receptors, Dopamine D1; Time Factors

2011